Specific shRNA knockout of ACSL4 could inhibit erastin-induced ferroptosis in KRAS mutant DLD-1 cells, indicating that ACSL4 was a key regulatory molecule for bromelain to effectively inhibit KRAS mutant colorectal cancer by stimulating ferroptosis (Park et al., 2018). This evidence concerns the gene ACSL4 and colorectal cancer.